Tech Center 1600 • Art Units: 1613 1614
This examiner grants 37% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17903586 | COMPOSITIONS AND METHODS FOR STABILIZING BIOMOLECULES | Non-Final OA | Massachusetts Institute of Technology |
| 18380984 | NanoMesh Drug Delivery for Treatment of Brain Tumors | Non-Final OA | The Johns Hopkins University |
| 18906308 | Compositions Containing a UV-Absorbing System Including Physical UV-Attenuating Material and Oil For Inhibiting Physical UV-Attenuating Material Aggregation | Non-Final OA | L'OREAL |
| 18544312 | PIGMENT DISPERSIONS WITH HYDROPHOBIC POLYMER | Final Rejection | L'OREAL |
| 17778353 | PROCESS FOR TREATING KERATIN FIBERS, COMPRISING A (POLY)CARBODIIMIDE COMPOUND, AN AQUEOUS DISPERSION OF PARTICLES OF POLYMER(S)AND A COLORING AGENT | Non-Final OA | L'OREAL |
| 17731815 | EMULSION COMPOSITIONS COMPRISING A POLYPHENOL AND LOW HLB NONIONIC COMPOUND | Non-Final OA | L'OREAL |
| 17870228 | ACTIVE INGREDIENT-CONTAINING NANOEMULSIONS | Non-Final OA | NICOVENTURES TRADING LIMITED |
| 18540213 | HAIR COSMETIC COMPOSITION | Final Rejection | KAO CORPORATION |
| 17759703 | WATER-IN-OIL EMULSION COSMETIC | Final Rejection | KAO CORPORATION |
| 18712869 | BIOACTIVE CERAMICS CUSTOMIZED FOR TISSUE HEALING AND METHODS FOR PRODUCING SAME | Non-Final OA | Collagen Matrix, Inc. |
| 17691107 | DOSAGE FORMS HAVING EQUIVALENT BIOCOMPARABLE PROFILES | Non-Final OA | Aquestive Therapeutics, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy